Company Profile

Integra LifeSciences Stock Price, News & Analysis

United StatesBiotechnologyNASDAQ

Company overview

Business overview

Integra LifeSciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Geographic Base and Sector Classification

Headquartered in the United States and listed on NASDAQ, Integra LifeSciences is followed within the biotech universe for its exposure to catalyst-driven execution.

Business Model Characteristics

Integra LifeSciences follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.

Position Within the Biotechnology Landscape

Compared with more mature healthcare peers, Integra LifeSciences sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.

Why the stock is moving

IART is trading with a steady catalyst profile while investors wait for the next headline that changes the story.

Future catalysts

Integra is still a medical-device execution story. The numbers matter less than whether the company's surgical and orthopedics portfolio can keep stabilizing, because the next move in a name like this usually comes from operating discipline rather than a single big product event.

Recent news

The five most recent feed items are shown below in reverse chronological order.

  1. 01
  2. 02
  3. 03
  4. 04
  5. 05

Similar stocks

Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.